$26.02
-0.02-0.07%
At Close: -
$22.18
-3.84-14.75%
After Hours: Dec 4, 9:25 AM EDT
15 minutes delayed
Comments
Loading...
Sector
Healthcare
Region
US
AUM
52.50M
Fund Score
Fidelity Disruptive Medicine ETF (NASDAQ:FMED) Quotes, Forecast and News Summary
Fidelity Disruptive Medicine ETF (NASDAQ: FMED) stock price, news, charts, stock research, profile.
| Open | $26.05 |
| High | $26.05 |
| 52 Wk High | $26.14 |
| AUM | 52.50M |
| Dividend | $0.00 |
| Ex-Div Date | Jun 21, 2024 |
| Volume | 1.35K |
| Market Cap | $84.73B |
| Mgmt Fee | 0.5% |
| P/E Ratio | 35.97 |
| Prev. Close | $26.04 |
| Low | $25.89 |
| 52 Wk Low | $19.88 |
| Shares Out | 2.12M |
| Yield | 0.00% |
| Div. Freq | U |
| Avg. Volume Daily | 5.68K |
| Beta | 1.21 |
| Avg. Expense Ratio | 0.5% |
| P/B Ratio | 4.62 |
Recent News
No news found
FAQ
How do I buy Fidelity Disruptive Medicine ETF (FMED) stock?
You can purchase shares of Fidelity Disruptive Medicine ETF (NASDAQ:FMED) through any online brokerage.
Who are Fidelity Disruptive Medicine ETF (FMED) competitors?
There are no as such competitors for Fidelity Disruptive Medicine ETF.
What is the forecast, or price target, for Fidelity Disruptive Medicine ETF (FMED) stock?
There is no analysis for Fidelity Disruptive Medicine ETF to provide a consensus price target.
What is the current price for Fidelity Disruptive Medicine ETF (FMED)?
The stock price for Fidelity Disruptive Medicine ETF (NASDAQ: FMED) is $22.18 last updated December 4, 2023 at 9:25 AM EST.
Does Fidelity Disruptive Medicine ETF (FMED) pay a dividend?
There are no upcoming dividends for Fidelity Disruptive Medicine ETF.
When is Fidelity Disruptive Medicine ETF (NASDAQ:FMED) reporting earnings?
Fidelity Disruptive Medicine ETF does not have any upcoming earnings scheduled.
Is Fidelity Disruptive Medicine ETF (FMED) going to split?
There is no upcoming split for Fidelity Disruptive Medicine ETF.
ETF Details
| Sector | Healthcare |
| Category | Mid Performer-Mid Growth |
| Investment Style | Large Cap Blend |
| Fund Inception | Feb 13, 2023 |
| Managers | Risteard Hogan William Shanley Michael Kim Charlie Hebard Tim Codrington Camille Carlstrom Niamh Brodie-Machura |
| Definition | Most of the stocks in this Equity Fund have average financial performance and average growth potential |
Investment Policy
The fund investing at least 80 percent of assets in securities of disruptive medicine companies. Fidelity's disruptive strategies seek to identify innovative developments that could signal new directions for delivering products and services to customers. Generally, these companies have or are developing new or unconventional ways of doing business that could disrupt and displace incumbents over time. This may include creating, providing, or contributing to new or expanded business models, value networks, pricing, and delivery of products and services.